A Phase 3, Multinational, Long-Term Follow-Up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study.

Participantes

• Rafael Sivera Mascaró

  Investigador Colaborador

• Ana Cano Sánchez

  Investigador Colaborador

• Inmaculada Pitarch Castellano

  Investigador Colaborador

• Maria Alvarez Cerezo

  Investigador Colaborador

• Nuria Muelas Gómez

  Investigador Principal

• Esteban Peiró Molina

  Investigador Colaborador

• Luján Diago Marsal

  Data Manager / Study Coordinator

• Silvia Pérez Albertos

  Data Manager / Study Coordinator

• Adrián Colás Benito

  Data Manager / Study Coordinator

• Marta Campo Rodrigo

  Data Manager / Study Coordinator

• Karolina Agata Aragon Gawinska

  Investigador Colaborador

Grupos

• Patología Neuromuscular y Ataxias

  

  Investigador Principal

  Teresa Sevilla Mantecón

• Regeneración y Trasplante Cardíaco

  

  Leader

  Pilar Sepúlveda Sanchis

• Unidad mixta de investigación en enfermedades raras (CIPF)

  

  Leader

  José María Millán Salvador

Financiadores - Promotores